- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01323686
Empiric Versus Imaging Guided Left Ventricular Lead Placement in Cardiac Resynchronization Therapy (ImagingCRT)
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Aarhus N, Denmark, DK-8200
- Department of Cardiology, Aarhus University Hospital, Skejby
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Symptomatic heart failure (New York Heart Association functional class II - IV) despite stabile optimal medical therapy.
- ECG with QRS ≥ 120 milliseconds and left bundle branch block (LBBB) or paced QRS ≥ 180 milliseconds.
- LV systolic dysfunction (Ejection Fraction ≤ 35%).
- written informed consent.
Exclusion Criteria:
- Expected lifetime < 6 months.
- Recent myocardial infarction (< 3 months).
- Pregnant or lactating.
- Inadequate echocardiographic images for determination of site with latest mechanical activation
- No written informed consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Imaging guided LV lead placement
|
LV lead placement guided by cardiac imaging using echocardiography, single-photon emission computed tomography, and CT to target a cardiac vein at the site of latest mechanical activation without scar tissue. Visualization of cardiac venous anatomy is performed using cardiac CT if not contraindicated by depressed renal function (estimated glomerular filtration rate <30 ml/min) or allergy to contrast media. In that case, a coronary venogram is used. |
No Intervention: Empiric LV lead placement
LV lead placement using standard clinical routine.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants with clinical response to CRT
Time Frame: 6 months after CRT implantation
|
Response to CRT defined as a combination of survival, free of hospitalization for heart failure, and improved functional status. The primary endpoint is attained if the patient is registered for one of the following three events:
|
6 months after CRT implantation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
All cause mortality
Time Frame: 6 months after CRT implantation
|
6 months after CRT implantation
|
|
Hospitalization for heart failure
Time Frame: 6 months after CRT implantation
|
6 months after CRT implantation
|
|
Changes in NYHA functional class
Time Frame: 6 months after CRT implantation
|
6 months after CRT implantation
|
|
Changes in 6-Minutes Hall Walk
Time Frame: 6 months after CRT implantation
|
6 months after CRT implantation
|
|
Changes in Quality of Life
Time Frame: 6 months after CRT implantation
|
Using Minnesota Living with Heart Failure questionnaire.
|
6 months after CRT implantation
|
Changes in Biochemical marker of heart failure
Time Frame: 6 months after CRT implantation
|
Nt-ProBNP
|
6 months after CRT implantation
|
Changes in LV Ejection Fraction
Time Frame: 6 months after CRT implantation
|
6 months after CRT implantation
|
|
Changes of LV end-diastolic volume
Time Frame: 6 months after CRT implantation
|
6 months after CRT implantation
|
|
Changes of LV end-systolic volume
Time Frame: 6 months after CRT implantation
|
6 months after CRT implantation
|
|
Changes of LV dyssynchrony
Time Frame: 6 months after CRT implantation
|
6 months after CRT implantation
|
|
Changes of mitral regurgitation grade
Time Frame: 6 months after CRT implantation
|
6 months after CRT implantation
|
|
Duration of CRT implantation
Time Frame: During CRT implantation
|
During CRT implantation
|
|
Complications
Time Frame: 6 months after CRT implantation
|
6 months after CRT implantation
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Jens C. Nielsen, Professor, PhD, DMSc, Aarhus University Hospital
- Principal Investigator: Anders Sommer, MD, Aarhus University Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- sksCRT
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
University Hospital, MontpellierCompletedHeart Failure | Diastolic Heart Failure | Systolic Heart Failure Stage CFrance
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
-
Lancaster General HospitalLouise von Hess Medical Research InstituteEnrolling by invitationDiastolic Heart FailureUnited States
-
Giresun UniversityIstanbul University - Cerrahpasa (IUC)RecruitingHeart Failure | Diastolic Heart Failure | Systolic Heart FailureTurkey
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Duke University; St. Paul's Hospital... and other collaboratorsActive, not recruitingHeart Diseases | Heart Failure | Transplant; Failure, Heart | Heart Transplant Failure and Rejection | Heart Failure,Congestive | Transplant FailureCanada, United States
Clinical Trials on Imaging guided optimal LV lead placement
-
Guy's and St Thomas' NHS Foundation TrustUnknown
-
Abbott Medical DevicesCompleted
-
Region SkaneCrafoord FoundationCompleted
-
Samir SabaCompletedHeart Failure, Wide QRS ComplexUnited States
-
Jaimie ManlucuWithdrawnLeft Bundle-Branch Block | Left Ventricular Dysfunction | Heart Failure,CongestiveCanada
-
Peter J PughUnknown
-
Michigan Heart, PCMedtronicUnknown
-
Lawson Health Research InstituteCompleted
-
StereotaxisMedtronicTerminatedHeart Failure, CongestiveUnited States, Canada, Italy
-
Oxford University Hospitals NHS TrustNational Institute for Health Research, United Kingdom; Heart Research UKCompleted